KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short term Debt (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Short term Debt for 17 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Short term Debt rose 10.51% to $2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 10.51% increase, with the full-year FY2025 number at $2.3 billion, up 10.51% from a year prior.
  • Short term Debt was $2.3 billion for Q4 2025 at Bristol Myers Squibb, down from $4.5 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $7.5 billion in Q1 2022 to a low of $1.1 billion in Q3 2024.
  • A 5-year average of $3.8 billion and a median of $3.5 billion in 2024 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: surged 323.3% in 2022, then tumbled 80.28% in 2024.
  • Bristol Myers Squibb's Short term Debt stood at $4.9 billion in 2021, then decreased by 13.82% to $4.3 billion in 2022, then fell by 26.85% to $3.1 billion in 2023, then tumbled by 34.4% to $2.0 billion in 2024, then increased by 10.51% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Short term Debt are $2.3 billion (Q4 2025), $4.5 billion (Q3 2025), and $4.7 billion (Q2 2025).